GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Touchstone International Medical Science Co Ltd (SHSE:688013) » Definitions » Beneish M-Score

Touchstone International Medical Science Co (SHSE:688013) Beneish M-Score : -1.21 (As of Dec. 14, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Touchstone International Medical Science Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.21 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Touchstone International Medical Science Co's Beneish M-Score or its related term are showing as below:

SHSE:688013' s Beneish M-Score Range Over the Past 10 Years
Min: -2.68   Med: -1.43   Max: 0.9
Current: -1.21

During the past 7 years, the highest Beneish M-Score of Touchstone International Medical Science Co was 0.90. The lowest was -2.68. And the median was -1.43.


Touchstone International Medical Science Co Beneish M-Score Historical Data

The historical data trend for Touchstone International Medical Science Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Touchstone International Medical Science Co Beneish M-Score Chart

Touchstone International Medical Science Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial - -2.11 -1.90 0.90 -2.29

Touchstone International Medical Science Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.13 -2.29 -2.68 0.03 -1.21

Competitive Comparison of Touchstone International Medical Science Co's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Touchstone International Medical Science Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Touchstone International Medical Science Co's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Touchstone International Medical Science Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Touchstone International Medical Science Co's Beneish M-Score falls into.



Touchstone International Medical Science Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Touchstone International Medical Science Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 3.0079+0.528 * 0.9597+0.404 * 0.885+0.892 * 1.1164+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9055+4.679 * -0.022815-0.327 * 2.6051
=-1.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Total Receivables was ¥23.3 Mil.
Revenue was 69.352 + 72.514 + 60.22 + 71.945 = ¥274.0 Mil.
Gross Profit was 40.585 + 41.778 + 35.252 + 38.944 = ¥156.6 Mil.
Total Current Assets was ¥500.0 Mil.
Total Assets was ¥671.9 Mil.
Property, Plant and Equipment(Net PPE) was ¥107.1 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥38.8 Mil.
Total Current Liabilities was ¥96.4 Mil.
Long-Term Debt & Capital Lease Obligation was ¥0.9 Mil.
Net Income was 13.9 + 17.499 + 11.352 + 14.199 = ¥57.0 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0.0 Mil.
Cash Flow from Operations was 18.614 + 11.114 + 8.793 + 33.759 = ¥72.3 Mil.
Total Receivables was ¥6.9 Mil.
Revenue was 54.208 + 68.02 + 59.472 + 63.764 = ¥245.5 Mil.
Gross Profit was 29.838 + 40.237 + 33.259 + 31.252 = ¥134.6 Mil.
Total Current Assets was ¥445.8 Mil.
Total Assets was ¥587.3 Mil.
Property, Plant and Equipment(Net PPE) was ¥77.4 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0.0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥38.4 Mil.
Total Current Liabilities was ¥31.1 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1.5 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(23.335 / 274.031) / (6.949 / 245.464)
=0.085155 / 0.02831
=3.0079

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(134.586 / 245.464) / (156.559 / 274.031)
=0.548292 / 0.571319
=0.9597

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (499.986 + 107.066) / 671.923) / (1 - (445.821 + 77.436) / 587.327)
=0.096545 / 0.109087
=0.885

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=274.031 / 245.464
=1.1164

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 77.436)) / (0 / (0 + 107.066))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(38.806 / 274.031) / (38.39 / 245.464)
=0.141612 / 0.156398
=0.9055

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.911 + 96.375) / 671.923) / ((1.546 + 31.097) / 587.327)
=0.144787 / 0.055579
=2.6051

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(56.95 - 0 - 72.28) / 671.923
=-0.022815

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Touchstone International Medical Science Co has a M-score of -1.21 signals that the company is likely to be a manipulator.


Touchstone International Medical Science Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Touchstone International Medical Science Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Touchstone International Medical Science Co Business Description

Traded in Other Exchanges
N/A
Address
278 Dongping Street, Suzhou Industrial Park, Suzhou, CHN, 215123
Touchstone International Medical Science Co Ltd is specialized in the development of surgical staplers that enhance clinical performance, minimise risk and improve patient outcomes. The company's products include Auto Purse String Clamp for Single Use (APS); Intraluminal Stapler for Single Use (CSC&ECSC); Endoscopic Linear Cutter and Single Use Loading Unit (ELC&ELCC); Intraluminal Stapler for Single Use (KOL); Linear Cutter and Reloads (LC&LCC); Linear Stapler and Reloads (LS&LSC); PPH Stapler and Purse Sets for Single Use (PPH); Tissue - Selecting Therapy Stapler (TST33); Tissue - Selecting Therapy Stapler (TST36); and Tissue - Selecting Therapy Stapler (Proctology Examination Kit).
Executives
Huang Bin Core technical personnel
Yang Cai Hong Director
Tian Guo Yu Directors, senior managers
Ding Shui Cheng Core technical personnel
Zhang Su Mei Core technical personnel
Liu Wei Director
Chen Wang Yu Director

Touchstone International Medical Science Co Headlines

No Headlines